Works matching IS 0008543X AND DT 2016 AND VI 122 AND IP 13


Results: 23
    1
    2
    3
    4
    5
    6
    7
    8
    9
    11
    12
    13
    14
    15

    Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma.

    Published in:
    2016
    By:
    • Orlowski, Robert Z.;
    • Nagler, Arnon;
    • Sonneveld, Pieter;
    • Bladé, Joan;
    • Hajek, Roman;
    • Spencer, Andrew;
    • Robak, Tadeusz;
    • Dmoszynska, Anna;
    • Horvath, Noemi;
    • Spicka, Ivan;
    • Sutherland, Heather J.;
    • Suvorov, Alexander N.;
    • Xiu, Liang;
    • Cakana, Andrew;
    • Parekh, Trilok;
    • San‐Miguel, Jesús F.
    Publication type:
    journal article
    16
    17
    18
    19
    20
    21
    22
    23